Abbott Laboratories shares were down Wednesdsay morning after the company laid out guidance for the first quarter of the year that was below market expectations.The stock was down 0.2% Wednesday while ...

Abbott's Q4 sales reached $10.97 billion, growing 7.2% YoY but falling short of expectations. Stifel and Piper Sandler analysts maintain positive ratings and price forecasts of $135 and $133 ...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by Wells Fargo & Company from $133.00 to $136 ...

While never guaranteed, this implies a greater likelihood of positive earnings news. If consensus is correct, Abbott will hit the middle of full-year guidance. If consensus is beat, they will ...

BTIG analyst Marie Thibault raised the firm’s price target on Abbott (ABT) to $140 from $139 and keeps a Buy rating on the shares. The firm ...